My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 371

    1.

    Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice.

    Oak JH, Cai H.

    Diabetes. 2007 Jan;56(1):118-26.PMID: 17192473 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase.

    Chalupsky K, Cai H.

    Proc Natl Acad Sci U S A. 2005 Jun 21;102(25):9056-61. Epub 2005 Jun 7.PMID: 15941833 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.

    Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS.

    Kidney Int. 2002 Jan;61(1):186-94.PMID: 11786100 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.

    Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F.

    Eur J Pharmacol. 2005 Mar 21;511(1):53-64.PMID: 15777779 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.

    Mollnau H, Wendt M, Szöcs K, Lassègue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Förstermann U, Meinertz T, Griendling K, Münzel T.

    Circ Res. 2002 Mar 8;90(4):E58-65.PMID: 11884382 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in type 1 diabetic mice.

    Luo JD, Wang YY, Fu WL, Wu J, Chen AF.

    Circulation. 2004 Oct 19;110(16):2484-93. Epub 2004 Jul 19.PMID: 15262829 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.

    Yamamoto E, Kataoka K, Shintaku H, Yamashita T, Tokutomi Y, Dong YF, Matsuba S, Ichijo H, Ogawa H, Kim-Mitsuyama S.

    Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2569-75. Epub 2007 Oct 11.PMID: 17932313 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effects of angiotensin II on nitric oxide generation in growing and resting rat aortic endothelial cells.

    Bayraktutan U.

    J Hypertens. 2003 Nov;21(11):2093-101.PMID: 14597853 [PubMed - indexed for MEDLINE]Related articles

    9.

    Increased aortic NADPH oxidase activity in rats with genetically high angiotensin-converting enzyme levels.

    Jalil JE, Pérez A, Ocaranza MP, Bargetto J, Galaz A, Lavandero S.

    Hypertension. 2005 Dec;46(6):1362-7. Epub 2005 Oct 17.PMID: 16230508 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress.

    Zhang H, Zhang J, Ungvari Z, Zhang C.

    Arterioscler Thromb Vasc Biol. 2009 Aug;29(8):1164-71. Epub 2009 May 28.PMID: 19478208 [PubMed - indexed for MEDLINE]Related articles

    11.

    Pitavastatin restores vascular dysfunction in insulin-resistant state by inhibiting NAD(P)H oxidase activity and uncoupled endothelial nitric oxide synthase-dependent superoxide production.

    Shinozaki K, Nishio Y, Ayajiki K, Yoshida Y, Masada M, Kashiwagi A, Okamura T.

    J Cardiovasc Pharmacol. 2007 Mar;49(3):122-30.PMID: 17414223 [PubMed - indexed for MEDLINE]Related articles

    12.

    Endothelial dysfunction in rat adjuvant-induced arthritis: vascular superoxide production by NAD(P)H oxidase and uncoupled endothelial nitric oxide synthase.

    Haruna Y, Morita Y, Komai N, Yada T, Sakuta T, Tomita N, Fox DA, Kashihara N.

    Arthritis Rheum. 2006 Jun;54(6):1847-55.PMID: 16729278 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor.

    Van Linthout S, Spillmann F, Lorenz M, Meloni M, Jacobs F, Egorova M, Stangl V, De Geest B, Schultheiss HP, Tschöpe C.

    Hypertension. 2009 Apr;53(4):682-7. Epub 2009 Mar 9.PMID: 19273745 [PubMed - indexed for MEDLINE]Related articles

    14.

    NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.

    Satoh M, Fujimoto S, Haruna Y, Arakawa S, Horike H, Komai N, Sasaki T, Tsujioka K, Makino H, Kashihara N.

    Am J Physiol Renal Physiol. 2005 Jun;288(6):F1144-52. Epub 2005 Feb 1.PMID: 15687247 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase.

    Savoia C, Ebrahimian T, He Y, Gratton JP, Schiffrin EL, Touyz RM.

    J Hypertens. 2006 Dec;24(12):2417-22. Erratum in: J Hypertens. 2007 Mar;25(3):729. PMID: 17082724 [PubMed - indexed for MEDLINE]Related articles

    16.

    Angiotensin II stimulates endothelial NO synthase phosphorylation in thoracic aorta of mice with abdominal aortic banding via type 2 receptor.

    Yayama K, Hiyoshi H, Imazu D, Okamoto H.

    Hypertension. 2006 Nov;48(5):958-64. Epub 2006 Sep 25.PMID: 17000928 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Mechanisms underlying endothelial dysfunction in diabetes mellitus.

    Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T.

    Circ Res. 2001 Feb 2;88(2):E14-22.PMID: 11157681 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effect of AT1 receptor blockade on hepatic redox status in SHR: possible relevance for endothelial function?

    Cediel E, Sanz-Rosa D, Oubina MP, de las Heras N, González Pacheco FR, Vegazo O, Jiménez J, Cachofeiro V, Lahera V.

    Am J Physiol Regul Integr Comp Physiol. 2003 Sep;285(3):R674-81. Epub 2003 May 29.PMID: 12775556 [PubMed - indexed for MEDLINE]Related articles

    19.

    Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats.

    Oelze M, Daiber A, Brandes RP, Hortmann M, Wenzel P, Hink U, Schulz E, Mollnau H, von Sandersleben A, Kleschyov AL, Mülsch A, Li H, Förstermann U, Münzel T.

    Hypertension. 2006 Oct;48(4):677-84. Epub 2006 Aug 28.PMID: 16940222 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II.

    Cai H, Li Z, Dikalov S, Holland SM, Hwang J, Jo H, Dudley SC Jr, Harrison DG.

    J Biol Chem. 2002 Dec 13;277(50):48311-7. Epub 2002 Oct 10.PMID: 12377764 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity